Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors

International Journal of Urology

Volumn 15, Issue 7, 2008, Pages 642-645

  Ishioka, Jun Ichiro ^a   Fujii, Yasuhisa ^b   Kageyama, Yukio ^a   Fukuda, Hiroshi ^a   Higashi, Yotsuo ^a   Kihara, Kazunori ^b  

^a SAITAMA CANCER CENTER   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cardiovascular disease; Germ cell neoplasm; High dose chemotherapy; Long term toxicity; Platinum dose

Indexed keywords

BLEOMYCIN; CANDESARTAN; CARBOPLATIN; CISPLATIN; DILTIAZEM; ETOPOSIDE; GLICLAZIDE; IFOSFAMIDE; MESNA; PACLITAXEL; PLATINUM; VINBLASTINE;

ADOLESCENT; ADULT; ANGINA PECTORIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVOR; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DATA ANALYSIS; DRUG MEGADOSE; FEMALE; FOLLOW UP; GERM CELL TUMOR; HEART ATRIUM FLUTTER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARDIOVASCULAR DISEASES; CISPLATIN; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; SURVIVORS; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 47249129920     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02066.x     Document Type: Article

References (10)

1. Motzer RJ, Mazumdar M, Bajorin MD, Bosl GJ, Lyn P, Vlamis V. High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J. Clin. Oncol. 1997 15 : 2546 52.
2. McCaffrey JA, Mazumdar M, Bajorin DF, Bosl GJ, Vlamis V, Motzer RJ. Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival. J. Clin. Oncol. 1997 15 : 2559 63.
3. Blanke C, Loehrer PJ, Nichols CR, Einhorn LH. A phase II trial of VP-16, ifosfamide, cisplatin, vinblastine, and bleomycin in advanced germ-cell tumors. Am. J. Clin. Oncol. 1996 19 : 487 91.
4. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J. Clin. Oncol. 1997 15 : 594 603.
5. Stoter G, Vendrik CP, Struyvenberg A et al. Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin. Cancer 1984 54 : 1521 4.
6. Einhorn LH. Chemotherapy of disseminated germ cell tumors. Cancer 1987 60 : 570 3.
7. Bokemeyer C, Kollmannsberger C, Meisner C et al. First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: a multivariate and matched-pair analysis. J. Clin. Oncol. 1999 17 : 3450 6.
8. Meinardi MT, Gietema JA, van der Graaf WTA et al. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J. Clin. Oncol. 2000 18 : 1725 32.
9. Huddart RA, Norman A, Shahidi M et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J. Clin. Oncol. 2003 21 : 1513 23.
10. Gietema JA, Meinardi MT, Messerschmidt J et al. Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer. Lancet 2000 355 : 1075 6.